5'-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-[2,2'-bithiophene]-5-carbaldehyde

Catalog No. :
ACGTAU091
CAS No. :
1421238-78-9
Molecular Formula :
C15H17BO3S2
Molecular Weight :
320.24

IUPAC Name:5'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-[2,2'-bithiophene]-5-carbaldehyde

5'-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-[2,2'-bithiophene]-5-carbaldehyde structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$71.00Login to see priceInquiryInquiry
250mg95%$123.00Login to see priceInquiryInquiry
1g95%$325.00Login to see priceInquiryInquiry
5g95%$1150.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5'-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-[2,2'-bithiophene]-5-carbaldehyde
IUPAC Name5'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-[2,2'-bithiophene]-5-carbaldehyde
Molecular FormulaC15H17BO3S2
Molecular Weight320.24
SMILESO=CC1=CC=C(C2=CC=C(B3OC(C)(C)C(C)(C)O3)S2)S1
InChI KeyGYVOXEOJJKSXKT-UHFFFAOYSA-N
Synonym5'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-[2,2'-bithiophene]-5-carbaldehyde;[2,2'-Bithiophene]-5-carboxaldehyde, 5'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-
CAS No.1421238-78-9

Synthetic Route by SureRoute

1. ACGTAU091 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACMFDN579 route compound structure diagram
    ACMFDN579479719-88-5 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGTAU091 route product structure diagram
    ACGTAU0911421238-78-9
Inquiry

2. ACGTAU091 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. ACORIU645 route compound structure diagram
    ACORIU645110046-60-1 In Stock
  4. Then
  5. ACGTAU091 route product structure diagram
    ACGTAU0911421238-78-9
Inquiry

Comments (0)